Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab. [electronic resource] by
- Iida, Mari
- Brand, Toni M
- Starr, Megan M
- Li, Chunrong
- Huppert, Evan J
- Luthar, Neha
- Pedersen, Mikkel W
- Horak, Ivan D
- Kragh, Michael
- Wheeler, Deric L
Producer: 20140902
In:
Neoplasia (New York, N.Y.) vol. 15
Availability: No items available.
|
|
6.
|
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. [electronic resource] by
- Iida, Mari
- Brand, Toni M
- Starr, Megan M
- Huppert, Evan J
- Luthar, Neha
- Bahrar, Harsh
- Coan, John P
- Pearson, Hannah E
- Salgia, Ravi
- Wheeler, Deric L
Producer: 20150713
In:
Molecular cancer vol. 13
Availability: No items available.
|